<?xml version="1.0" encoding="UTF-8"?>
<p>Though vaccines and antiviral are available that can provide protection from influenza infection, new viral strains emerge continuously due to the plasticity of the influenza genome. An alternative protection methodology that is based on the isolation of a panel of monoclonal antibodies derived from Ig G+ memory B cells of healthy human subjects that have a capability of recognizing new viral strains is discussed in Grandea III et al. [
 <xref ref-type="bibr" rid="CR24">24</xref>].
</p>
